OMCL stock has delivered an impressive performance in the past year. Shares of the company have risen 47.1% against the industry's 7.9% decline. The S&P 500 composite has increased 18.5% in the said ...

Pharmacy leaders across the country are implementing initiatives to improve efficiency, reduce costs and enhance patient care. Below are responses from eight pharmacy leaders who were asked: What is ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Omnicell , Inc. (NASDAQ:OMCL), a leading provider of medication management solutions in the healthcare technology sector, has been navigating a complex market environment characterized by both ...

Here at Omnicell, we are entering 2025 with a renewed ... automated dispensing systems and the product portion of our central pharmacy dispensing services and IV compounding services as of ...

Omnicell (OMCL) came out with quarterly earnings of $0.60 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.33 per share a year ago. These figures ...

OMNICELL ($OMCL) posted quarterly earnings results on Thursday, February 6th. The company reported earnings of $0.60 per share, beating estimates of $0.59 by $0.01 ...

Omnicell delivers strong fourth quarter financial results. Results exceed previously issued full year guidance for bookings, total revenues, and non-GAAP EBITDA. FORT WORTH, Texas ...

("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in transforming the pharmacy and nursing care delivery model, today announced results for its fiscal year and fourth ...